Integrating electrical impedance score into decision to biopsy increases biopsy efficiency

Background: Number needed to biopsy (NNB) is a measure of diagnostic accuracy and is measured as the number of lesions biopsied divided by the number of lesions that are positive for a disease outcome. Increasing biopsy efficiency can be achieved using noninvasive imaging technologies. One such technology relies on the principle of electrical impedance spectroscopy (EIS) to classify malignant versus benign lesions before biopsy. Nevisense is an FDA-approved device that has demonstrated high sensitivity in melanoma diagnosis (Scibase, Stockholm, Sweden).
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research